Oxford Biomedica plc (LSE:OXB) entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH on December 4, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
315 GBX | -1.56% | -3.96% | +43.18% |
09/05 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
09/05 | Molten Ventures wins UK MoD supply contract | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.18% | 400M | |
+3.91% | 108B | |
+11.25% | 104B | |
+1.28% | 22.33B | |
-13.01% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.96% | 17.64B | |
+3.79% | 14.05B | |
+36.44% | 12.51B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH.